| Year |
Citation |
Score |
| 2020 |
Lin RJ, Baser RE, Elko TA, Korc-Grodzicki B, Shahrokni A, Maloy MA, Young JW, Tamari R, Shah GL, Shaffer BC, Scordo M, Sauter CS, Ponce DM, Politikos I, Perales MA, et al. Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 32694543 DOI: 10.1038/S41409-020-01001-2 |
0.344 |
|
| 2020 |
Olin RL, Fretham C, Pasquini MC, Arora M, Bhatt VR, Derman B, Giralt SA, Huang LW, Koll T, Lee SM, Lin RJ, Pang L, Popat UR, Weisdorf DJ, Artz A. Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes. Blood Advances. 4: 2810-2820. PMID 32574365 DOI: 10.1182/Bloodadvances.2020001719 |
0.308 |
|
| 2020 |
Lin RJ, Ho C, Devlin SM, Ruiz JD, Maloy MA, Shah GL, Perales MA, Dahi PB, Giralt SA, Scordo M, Schöder H, Hamlin PA, Sigler AM, Dogan A, Sauter CS. Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma. Bone Marrow Transplantation. PMID 32404978 DOI: 10.1038/S41409-020-0942-1 |
0.325 |
|
| 2020 |
Lin RJ, Michaud L, Lobaugh SM, Nakajima R, Mauguen A, Elko TA, Ruiz JD, Maloy MA, Sauter CS, Dahi PB, Perales MA, Shah GL, Castillo Flores N, Sanchez-Escamilla M, Tomas AA, et al. The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients. Leukemia & Lymphoma. 1-9. PMID 32228298 DOI: 10.1080/10428194.2020.1742909 |
0.381 |
|
| 2020 |
Lin RJ, Cohen AG, Stabler SM, Devlin SM, Elko TA, Maloy MA, Korc-Grodzicki B, Alexander K, Kramer D, Sanchez-Escamilla M, Castillo Flores N, Barker JN, Cho C, Dahi PB, Gyurkocza B, et al. Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients. Journal of Palliative Medicine. PMID 32216649 DOI: 10.1089/Jpm.2019.0611 |
0.384 |
|
| 2020 |
Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, ... ... Lin RJ, et al. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. The New England Journal of Medicine. 382: 822-834. PMID 32101664 DOI: 10.1056/Nejmoa1900623 |
0.317 |
|
| 2020 |
Lin RJ, Lobaugh SM, Pennisi M, Chan HT, Batlevi Y, Ruiz JD, Elko TA, Maloy MA, Batlevi CL, Dahi PB, Giralt SA, Hamlin PA, Mead E, Noy A, Palomba ML, et al. Impact and safety of chimeric antigen receptor T cell therapy in older, vulnerable patients with relapsed/refractory large b-cell lymphoma. Haematologica. PMID 32079691 DOI: 10.3324/Haematol.2019.243246 |
0.308 |
|
| 2020 |
Pennisi M, Cho C, Devlin SM, Ruiz JD, Maloy MA, Tomas AA, Castillo N, Lin RJ, Politikos I, Sanchez-Escamilla M, Scordo M, Shah GL, Barker JN, Castro-Malaspina H, Gyurkocza B, et al. Don't Let the HCT-CI Fool You: Similar Outcomes with Myeloablative CD34+ Selected Allo-HCT Compared to Unmodified RIC Allo-HCT in Patients with AML or MDS and High Comorbidity Scores. Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.704 |
0.314 |
|
| 2020 |
Shouval R, Fein JA, Devlin SM, Maloy MA, Flores NC, Lin RJ, Politikos I, Sanchez M, Scordo M, Shah GL, Barker JN, Giralt SA, Gyurkocza B, Jakubowski AA, Papadopoulos EB, et al. The Impact of Individual Co-Morbidities in Myeloablative Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 26: S141. DOI: 10.1016/J.Bbmt.2019.12.669 |
0.358 |
|
| 2020 |
Brambilla CZ, Ruiz JD, Lobaugh SM, Dahi PB, Young JW, Gyurkocza B, Shaffer BC, Ponce DM, Tamari R, Escamilla MS, Flores NC, Politikos I, Scordo M, Shah GL, Cho C, ... Lin RJ, et al. Long-Term Survival in Patients with AML or MDS Relapsed after Allogeneic Hematopoietic Cell Transplantation: Importance of Second Cell Therapy Biology of Blood and Marrow Transplantation. 26: S97-S98. DOI: 10.1016/J.Bbmt.2019.12.598 |
0.386 |
|
| 2020 |
Lin RJ, Baser RE, Elko TA, Korc-Grodzicki B, Shahrokni A, Maloy MA, Young JW, Tamari R, Shah GL, Shaffer BC, Scordo M, Sauter CS, Ponce DM, Politikos I, Perales M, et al. Burden and Impact of Geriatric Syndromes in 2-Year, Progression-Free Survivors of Older Allogeneic Hematopoietic Cell Transplant Recipients – a Landmark Analysis Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.232 |
0.37 |
|
| 2020 |
Mishra A, Preussler JM, Al-Mansour Z, Bachanova V, Bhatt VR, Bredeson C, Chhabra S, D'Souza A, Dahi PB, DeFilipp Z, Gowda L, Hacker ED, Hashmi SK, Howard DS, Jakubowski AA, ... ... Lin RJ, et al. Transplant Physicians’ Attitudes on Candidacy for Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Patients: The Need for a Standardized Geriatric Assessment (GA) Tool Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.115 |
0.331 |
|
| 2019 |
Lin RJ, Klepin HD. Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies. Hematology. American Society of Hematology. Education Program. 2019: 59-62. PMID 31808857 DOI: 10.1182/Hematology.2019000076 |
0.301 |
|
| 2019 |
Lin RJ, Sanchez M, Abbi K, Devlin SM, Jakubowski AA, Papadopoulos EB, Barker JN, Tamari R, Young JW, Gyurkocza B, Ponce DM, Dahi PB, Maloy MA, Giralt SA, Perales MA, et al. Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34 selected graft. Bone Marrow Transplantation. PMID 31645667 DOI: 10.1038/S41409-019-0723-X |
0.303 |
|
| 2019 |
Lin RJ, Elko TA, Devlin SM, Shahrokni A, Jakubowski AA, Dahi PB, Perales MA, Tamari R, Shaffer BC, Sauter CS, Papadopoulos EB, Gyurkocza B, Korc-Grodzicki B, Barker JN, Maloy MA, et al. Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies. Bone Marrow Transplantation. PMID 31471572 DOI: 10.1038/S41409-019-0654-6 |
0.394 |
|
| 2019 |
Lin RJ, Dahi PB, Shahrokni A, Sarraf S, Korc-Grodzicki B, Devlin SM, Maloy MA, Shah GL, Jakubowski AA, Giralt SA. Feasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation - a single institution pilot study. Leukemia & Lymphoma. 1-4. PMID 31226901 DOI: 10.1080/10428194.2019.1630621 |
0.329 |
|
| 2019 |
Scordo M, Lin RJ, Sauter CS. Hematopoietic-cell transplantation for lymphoma in the era of genetically engineered cellular therapy: it's not quite time to scrap the old vehicle for the new car. Current Opinion in Hematology. 26: 288-293. PMID 31170111 DOI: 10.1097/Moh.0000000000000515 |
0.323 |
|
| 2019 |
Lin RJ, Hilden PD, Elko TA, Dahi PB, Shahrokni A, Jakubowski AA, Perales MA, Sauter CS, Castro-Malaspina HR, Barker JN, Shaffer BC, Tamari R, Papadopoulos EB, Maloy MA, Korc-Grodzicki B, et al. Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults. Blood Advances. 3: 12-20. PMID 30606722 DOI: 10.1182/Bloodadvances.2018028241 |
0.377 |
|
| 2019 |
Lin RJ, Elko TA, Devlin SM, Flynn J, Jakubowski AA, Shahrokni A, Dahi P, Perales M, Sanchez-Escamilla M, Tamari R, Shaffer BC, Sauter CS, Papadopoulos EB, Castro-Malaspina H, Gyurkocza B, et al. Impact of geriatric vulnerability on outcomes of older patients in allogeneic hematopoietic cell transplantation. Journal of Clinical Oncology. 37: 7017-7017. DOI: 10.1200/Jco.2019.37.15_Suppl.7017 |
0.373 |
|
| 2019 |
Lin RJ, Lobaugh SM, Pennisi M, Chan JT, Batlevi Y, Ruiz JD, Elko TA, Maloy MA, Batlevi CL, Dahi PB, Giralt SA, Mead E, Noy A, Palomba ML, Santomasso B, et al. Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Blood. 134: 1603-1603. DOI: 10.1182/Blood-2019-125162 |
0.329 |
|
| 2019 |
Lin RJ, Michaud L, Lobaugh SM, Nakajima R, Elko TA, Ruiz JD, Sauter CS, Dahi PB, Maloy MA, Perales M, Kim SJ, Korc-Grodzicki B, Devlin SM, Scordo M, Schoder H, et al. The Geriatric Syndrome of Sarcopenia Impacts Allogeneic Hematopoietic Cell Transplantation Outcomes in Combination with Multi-Morbidity and Functional Impairment Blood. 134: 4508-4508. DOI: 10.1182/Blood-2019-125141 |
0.363 |
|
| 2019 |
Adhi FI, Littmann ER, Taur Y, Maloy MA, Markey KA, Fontana E, Amoretti LA, Wright R, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Yáñez L, Brereton D, Clurman A, et al. Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation Blood. 134: 3264-3264. DOI: 10.1182/Blood-2019-124902 |
0.324 |
|
| 2019 |
Olin RL, Fretham C, Pasquini MC, Arora M, Bhatt VR, Derman B, Giralt SA, Huang L, Koll TT, Lee SM, Lin RJ, Pang L, Popat U, Weisdorf DJ, Artz AS. Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A Multicenter Retrospective Study Blood. 134: 4606-4606. DOI: 10.1182/Blood-2019-123598 |
0.342 |
|
| 2019 |
Dahi PB, Lin RJ, Shahrokni A, Maloy MA, Devlin SM, Petrlik E, Ayala J, Brown S, Giralt SA, Jakubowski AA. Feasibility and Clinical Utility of Electronic Geriatric Assessment (eGA) in Older Patients Undergoing Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.432 |
0.376 |
|
| 2019 |
Lin RJ, Alexander K, Cohen A, Stabler SM, Kramer D, Elko TA, Jakubowski AA, Maloy MA, Giralt SA. Characteristics of Peri-Transplant Palliative Supportive Care Consultation Among Older Allogeneic Hematopoietic Cell Transplant Recipients Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.421 |
0.377 |
|
| 2019 |
Lin RJ, Elko TA, Devlin SM, Perales M, Papadopoulos EB, Castro-Malaspina H, Gyurkocza B, Shaffer BC, Tamari R, Tallman M, Stein E, Goldberg AD, Maloy MA, Giralt SA, Jakubowski AA. Impact of Pre-Transplant Measurable Residual Disease on Relapse Incidence and Progression-Free Survival in Older AML/MDS Patients Following Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.391 |
0.37 |
|
| 2019 |
Elko TA, Lin RJ, Jakubowski AA, Perales M, Maloy MA, Applebaum AJ, Giralt SA. Prevalence and Characteristics of Caregiver Distress One-Year after Allogeneic Hematopoietic Cell Transplant in an Older Cohort of Patients - a Single Institution Experience Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.177 |
0.317 |
|
| 2018 |
Lin RJ, Ho C, Hilden PD, Barker JN, Giralt SA, Hamlin PA, Jakubowski AA, Castro-Malaspina HR, Robinson KS, Papadopoulos EB, Perales MA, Sauter CS. Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations. British Journal of Haematology. PMID 30537212 DOI: 10.1111/Bjh.15721 |
0.389 |
|
| 2018 |
Lin RJ, Elko TA, Perales MA, Alexander K, Jakubowski AA, Devlin SM, Dahi PB, Papadopoulos EB, Klimek VM, Giralt SA, Nelson JE. End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer center. Bone Marrow Transplantation. PMID 30135464 DOI: 10.1038/S41409-018-0311-5 |
0.361 |
|
| 2018 |
Lin RJ, Shahrokni A, Dahi PB, Jakubowski AA, Devlin SM, Maloy MA, Robinson KS, Perales MA, Shah GL, Korc-Grodzicki B, Giralt SA. Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience. Bone Marrow Transplantation. PMID 29523890 DOI: 10.1038/S41409-018-0151-3 |
0.319 |
|
| 2018 |
Lin RJ, Elko TA, Hilden P, Dahi PB, Jakubowski AA, Perales M, Barker J, Castro-Malaspina HR, Shaffer BC, Shahrokni A, Tamari R, Papadopoulos EB, Sauter CS, Maloy M, Korc-Grodzicki B, et al. Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults Blood. 132: 3370-3370. DOI: 10.1182/Blood-2018-99-113876 |
0.325 |
|
| 2018 |
Lin RJ, Elko TA, Devlin SM, Jakubowski AA, Shahrokni A, Dahi PB, Perales M, Tamari R, Shaffer BC, Sauter CS, Papadopoulos EB, Castro-Malaspina HR, Barker J, Maloy M, Korc-Grodzicki B, et al. A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation Blood. 132: 2176-2176. DOI: 10.1182/Blood-2018-99-113688 |
0.365 |
|
| 2018 |
Lin RJ, Ho C, Hilden P, Barker J, Giralt S, Hamlin PA, Jakubowski AA, Castro-Malaspina H, Papadopoulos EB, Perales M, Sauter CS. Allogeneic Stem Cell Transplantation Overcomes the Negative Prognostic Impact of TP53 Alterations in Mantle Cell Lymphoma Blood. 132: 4668-4668. DOI: 10.1182/Blood-2018-99-113186 |
0.377 |
|
| 2018 |
Lin RJ, Perales M, Shahrokni A, Maloy M, Devlin SM, Jakubowski AA, Dahi PB, Shah GL, Korc-Grodzicki B, Giralt SA. Prevalence of Functional Impairment and Geriatric Vulnerability during Pre-Transplant Geriatric Assessment in an Academic Hematopoietic Cell Transplantation Center Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.259 |
0.327 |
|
| 2017 |
Lin RJ, Ma H, Guo R, Troxel AB, Diefenbach CS. Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicities. British Journal of Haematology. PMID 29143301 DOI: 10.1111/Bjh.15027 |
0.324 |
|
| 2017 |
Lin RJ, Behera M, Diefenbach CS, Flowers CR. The Role of Anthracycline and Comprehensive Geriatric Assessment for Elderly Patients with Diffuse Large B-cell Lymphoma. Blood. PMID 28814386 DOI: 10.1182/Blood-2017-05-736975 |
0.317 |
|
| 2017 |
Lin RJ, Ma H, Guo R, Grossbard ML, Troxel AB, Magid Diefenbach CS. Polypharmacy and potentially inappropriate medication use in older patients with aggressive non-Hodgkin lymphoma (NHL) leads to inferior survival and increased treatment-related toxicities. Journal of Clinical Oncology. 35: 10039-10039. DOI: 10.1200/Jco.2017.35.15_Suppl.10039 |
0.343 |
|
| 2016 |
Lin RJ, Guo R, Becker DJ, Grossbard ML, Diefenbach CSM. Adverse impact of polypharmacy and potentially inappropriate medication use in newly diagnosed, elderly lymphoma patients. Journal of Clinical Oncology. 34: 6562-6562. DOI: 10.1200/Jco.2016.34.15_Suppl.6562 |
0.318 |
|
| 2015 |
Lin RJ, Evans AT, Wakeman K, Unterbrink M. A Mixed-Methods Study of Pain-related Quality of Life in Sickle Cell Vaso-Occlusive Crises. Hemoglobin. 1-5. PMID 26114739 DOI: 10.3109/03630269.2015.1055576 |
0.329 |
|
| 2013 |
Lin RJ, Larson RA, van Besien K, Rich ES. Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation. Case Reports in Hematology. 2013: 140138. PMID 23607004 DOI: 10.1155/2013/140138 |
0.353 |
|
| 2010 |
Lin RJ, Curran JJ, Zimmerman TM, Song J, Niewold TB, Sweiss NJ. Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 16: 90-1. PMID 20130475 DOI: 10.1097/Rhu.0B013E3181D0Bfef |
0.3 |
|
| 2001 |
Lin RJ, Sternsdorf T, Tini M, Evans RM. Transcriptional regulation in acute promyelocytic leukemia. Oncogene. 20: 7204-15. PMID 11704848 DOI: 10.1038/Sj.Onc.1204853 |
0.483 |
|
| 2000 |
Lin RJ, Evans RM. Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers. Molecular Cell. 5: 821-30. PMID 10882118 DOI: 10.1016/S1097-2765(00)80322-6 |
0.473 |
|
| 1999 |
Xie W, Hong H, Yang NN, Lin RJ, Simon CM, Stallcup MR, Evans RM. Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Molecular Endocrinology (Baltimore, Md.). 13: 2151-62. PMID 10598588 DOI: 10.1210/Mend.13.12.0381 |
0.445 |
|
| 1999 |
Chen H, Lin RJ, Xie W, Wilpitz D, Evans RM. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell. 98: 675-86. PMID 10490106 DOI: 10.1016/S0092-8674(00)80054-9 |
0.462 |
|
| 1999 |
Lin RJ, Egan DA, Evans RM. Molecular genetics of acute promyelocytic leukemia. Trends in Genetics : Tig. 15: 179-84. PMID 10322484 DOI: 10.1016/S0168-9525(99)01710-2 |
0.477 |
|
| 1998 |
Lin RJ, Kao HY, Ordentlich P, Evans RM. The transcriptional basis of steroid physiology. Cold Spring Harbor Symposia On Quantitative Biology. 63: 577-85. PMID 10384323 DOI: 10.1101/Sqb.1998.63.577 |
0.432 |
|
| 1998 |
Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM, Albagli O. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Research. 26: 4645-51. PMID 9753732 DOI: 10.1093/Nar/26.20.4645 |
0.47 |
|
| 1998 |
Lin RJ, Nagy L, Inoue S, Shao W, Miller WH, Evans RM. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature. 391: 811-4. PMID 9486654 DOI: 10.1038/35895 |
0.487 |
|
| 1997 |
Dhordain P, Albagli O, Lin RJ, Ansieau S, Quief S, Leutz A, Kerckaert JP, Evans RM, Leprince D. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proceedings of the National Academy of Sciences of the United States of America. 94: 10762-7. PMID 9380707 DOI: 10.1073/Pnas.94.20.10762 |
0.469 |
|
| 1997 |
Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 90: 569-80. PMID 9267036 DOI: 10.1016/S0092-8674(00)80516-4 |
0.461 |
|
| 1997 |
Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell. 89: 373-80. PMID 9150137 DOI: 10.1016/S0092-8674(00)80218-4 |
0.483 |
|
| Show low-probability matches. |